| Literature DB >> 28746520 |
Cristiane Fernanda da Silva1, Miria Suzana Burgos1, Priscila Tatiana da Silva1, Leandro Tibiriçá Burgos1, Letícia Welser1, Ana Paula Sehn1, Jorge André Horta1, Elza Daniel de Mello2, Cézane Priscila Reuter1.
Abstract
Background: Little has been studied on heart rate and its relationship with metabolic disorders. Objective: To identify possible association between heart rate (HR) and metabolic disorders in children and adolescents.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28746520 PMCID: PMC5586225 DOI: 10.5935/abc.20170103
Source DB: PubMed Journal: Arq Bras Cardiol ISSN: 0066-782X Impact factor: 2.000
Descriptive characteristics of subjects. Santa Cruz do Sul, RS, 2014-2015
| n (%) | |
|---|---|
| Male | 903 (43) |
| Female | 1195 (57) |
| I | 517 (25) |
| II | 510 (24) |
| III | 437 (21) |
| IV | 478 (23) |
| V | 156 (7) |
| Age (years) | 11.50 (2.77) |
| Resting HR(bpm) | 82.67 (10.40) |
| Effort HR (bpm) | 168.40 (22.47) |
Comparison of mean values of cardiometabolic indicators according to resting HR quartiles
| Quartiles of resting HR | p | ||||
|---|---|---|---|---|---|
| SBP (mmHg) | 106.94 (14.61) | 105.95 (13.85) | 105.03 (14.28) | 107.02 (14.94) | 0.081 |
| DBP (mmHg) | 65.47 (10.60) | 64.62 (10.75) | 64.49 (11,01) | 65.18 (11.19) | 0.412 |
| Glucose (mg/dL) | 89.85 (9.52) | 89.44 (9.29) | 89.31 (9.49) | 90.24 (9.14) | 0.354 |
| TC (mg/dL) | 158.62 (30.93) | 160.60 (30.20) | 161.85 (30.32) | 163.70 (31.22) | 0.055 |
| HDL-C (mg/dL) | 62.16 (10.86) | 60.95 (11.48) | 60.77 (12.40) | 60.49 (11.30) | 0.098 |
| LDL-C (mg/dL) | 82.66 (28.45) | 85.11 (25.93) | 86.47 (26.03) | 88.68 (26.61) | 0.003[ |
| TG (mg/dL) | 69.82 (30.76) | 71.80 (31.61) | 72.75 (36.96) | 71.73 (34.40) | 0.552 |
| UA (mg/dL) | 4.30 (1.57) | 4.14 (1.26) | 4.16 (2.44) | 4.16 (1.19) | 0.381 |
| DP (bpm/mmHg) | 7354.33 (1073.25) | 8364.62 (1136.90) | 9087.20 (1253.50) | 10257.53 (1522.47) | < 0.001[ |
| mVO2 (mlO2/100.LV.min) | 3.99 (1.50) | 5.41 (1.59) | 6.42 (1.75) | 8.06 (2.13) | < 0.001[ |
| PP (mmHg) | 41.47 (9.69) | 41.34 (9.22) | 40.54 (9.56) | 41.84 (10.68) | 0.176 |
Analysis of variance (ANOVA); Data expressed as mean (standard deviation); Q1: quartile 1; Q2: quartile 2; Q3: quartile 3; Q4: quartile 4; Bpm: beats per minute; SBP: systolic blood pressure; DBP: diastolic blood pressure; TC: total cholesterol; HDL-C: high-density lipoprotein; LDL-C: low-density lipoprotein; TG: triglycerides; UA: uric acid; DP: double-product; MVO2: consumption of oxygen by the myocardium; PP: pulse pressure; Tukey Post Hoc:
Significant difference from Q1 to Q4 (p = 0.002);
significant difference from Q1 to Q2 (p < 0.001), for Q3 (p < 0.001) and for Q4 (p < 0.001); (p < 0.001), from Q2 to Q4 (p < 0.001) and from Q3 to Q4 (p < 0.001).
Comparison of the mean values of the cardiometabolic indicators according to the quartiles of the effort HR
| Quartiles of effort FC | p | ||||
|---|---|---|---|---|---|
| Q1 (n = 508) | Q2 (n = 537) | Q3 (n = 506) | Q4 (n = 547) | ||
| < 152 bpm | 152-171 bpm | 172-184 bpm | ≥ 185 bpm | ||
| SBP (mmHg) | 103.72 (13.80) | 105.44 (13.83) | 106.89 (14.69) | 108.71 (14.95) | < 0.001[ |
| DBP (mmHg) | 63.52 (10.59) | 64.25 (10.28) | 65.47 (10.81) | 66.43 (11.63) | < 0.001[ |
| Glucose (mg/dL) | 89.23 (9.90) | 89.93 (9.40) | 89.02 (8.72) | 90.58 (9.34) | 0.028[ |
| TC (mg/dL) | 159,21 (30.31) | 161.47 (27.42) | 162.73 (33.54) | 161.45 (31.34) | 0.323 |
| HDL-C (mg/dL) | 60.80 (11.86) | 61.42 (11.16) | 60.62 (11.54) | 61.45 (11.63) | 0.544 |
| LDL-C (mg/dL) | 84.12 (26.79) | 85.84 (24.29) | 87.80 (28.78) | 85.33 (27.33) | 0.175 |
| TG (mg/dL) | 70.82 (31.96) | 70.25 (31.88) | 72.25 (36.33) | 72.83 (34.00) | 0.559 |
| Uric acid (mg/dL) | 3.91 (1.20) | 4.28 (2.33) | 4.16 (1.21) | 4.40 (1.70) | < 0.001[ |
Analysis of variance (ANOVA); Data expressed as mean (standard deviation); Q1: quartile 1; Q2: quartile 2; Q3: quartile 3; Q4: quartile 4; Bpm: beats per minute; SBP: systolic blood pressure; DBP: diastolic blood pressure; HDL-C: high-density lipoprotein; LDL-C: low density lipoprotein; Post Hoc of Tukey:
Significant difference of Q1 for Q3 (p = 0.002) and Q1 for Q4 (p < 0.001);
significant difference from Q1 to Q3 (p = 0.022) and Q1 to Q4 (p < 0.001);
significant difference from Q3 to Q4 (p = 0.035);
significant difference from Q1 to Q2 (p = 0.002) and Q1 to Q4 (p < 0.001).
Association between heart rate and cardiometabolic indicators Rest HR Effort HR
| Rest HR | Effort HR | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| SBP | 0.08 | 0.02 | 0.001 | -0.00 | 0.967 | 0.08 | 0.05 | 0.096 | 0.13 | < 0.001 |
| DBP | 0.02 | 0.03 | 0.500 | -0.01 | 0.795 | 0.01 | 0.07 | 0.884 | 0.11 | < 0.001 |
| Glucose | 0.05 | 0.02 | 0.034 | 0.01 | 0.684 | 0.01 | 0.05 | 0.911 | 0.05 | 0.030 |
| Total cholesterol | 0.16 | 0.08 | 0.060 | 0.07 | 0.001 | -0.22 | 0.19 | 0.252 | 0.04 | 0.100 |
| HDL-C | -0.20 | 0.09 | 0.022 | -0.05 | 0.019 | 0.27 | 0.19 | 0.156 | 0.02 | 0.451 |
| LDL-C | -0.14 | 0.08 | 0.096 | 0.09 | < 0.001 | 0.26 | 0.19 | 0.168 | 0.03 | 0.122 |
| Triglycerides | -0.02 | 0.02 | 0.285 | 0.04 | 0.062 | 0.02 | 0.04 | 0.631 | 0.01 | 0.546 |
| Uric acid | -0.03 | 0,13 | 0.806 | -0.03 | 0.132 | 0.73 | 0.30 | 0.015 | 0.09 | < 0.001 |
| DP | 0.01 | 0.00 | < 0.001 | 0.678 | < 0.001 | - | - | - | - | - |
| mVO2 | 3.46 | 0.07 | < 0.001 | 0.678 | < 0.001 | - | - | - | - | - |
| PP | 0.07 | 0.02 | 0.003 | 0.005 | 0.820 | - | - | - | - | - |
Linear regression adjusted for sex, age, body mass index and maturational stage; SE: standard error; R: Pearson's correlation;
value of significance for the linear regression test;
significance value for the Pearson correlation test; HR: heart rate; SBP: systolic blood pressure; DBP: diastolic blood pressure; HDL-C: high-density lipoprotein; LDL-C: low-density lipoprotein; DP: double-product; MVO2: consumption of oxygen by the myocardium; PP: pulse pressure.